In the recent RESCUE (Reduction in Inflammation in Patients with Advanced Chronic Renal Disease Utilizing Antibody-Mediated IL-6 Inhibition) trial, a significant reduction in high-sensitivity C-reactive protein (hsCRP) was observed. The gene discussed is IL6; the disease is chronic kidney disease.